Keyphrases
Mycobacterium Tuberculosis (M. tb)
100%
Mycobacterium Abscessus
76%
Mycobacterium
48%
Drug Discovery
40%
Tuberculosis
37%
Antimicrobial Resistance
34%
Antibiotics
31%
Phenotypic Screen
28%
Non-replicating
27%
Drug Target
25%
Minimum Inhibitory Concentration
21%
In Vitro Model
20%
Mycobacterium Bovis BCG
20%
Resistant mutants
19%
M. Bovis BCG
18%
Honey
18%
Imipenem-relebactam
18%
Antimycobacterial Activity
18%
Manuka Honey
18%
Non-replicating Persistence
18%
Amoxicillin
18%
Mode of Action
17%
Cystic Fibrosis
16%
Molecular Targets
15%
Fatty Acid Synthase
15%
Mycolic Acid
14%
Novel Inhibitors
13%
AstA
13%
Current Treatment
13%
Whole Genome Sequencing
13%
Medical-grade Honey
12%
Causative Agents
12%
Tuberculosis Drug Discovery
12%
Multidrug-resistant Infection
12%
KasA
12%
Target Assignment
12%
Lactams
12%
Antimicrobial
11%
Antitubercular Agents
11%
High-throughput
11%
Relebactam
11%
Single nucleotide Polymorphism
11%
Antitubercular
11%
Cellular Targets
11%
Tuberculosis Drugs
10%
Antibiotic Discovery
10%
In Vivo Efficacy
10%
Amikacin
10%
Target Engagement
10%
High-throughput Screening
9%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
65%
Mycobacterium Tuberculosis
54%
Drug Discovery
49%
Mycobacterium abscessus
48%
Antiinfective Agent
37%
Mycobacterium Bovis BCG
36%
Mycobacteria
33%
Infectious Agent
28%
Antimicrobial Resistance
28%
Antibiotics
20%
Relebactam
18%
Mycolic Acid
18%
Molecular Target
18%
Imipenem
18%
Cystic Fibrosis
15%
Antimycobacterial Agent
13%
Minimum Inhibitory Concentration
13%
Lactam
12%
Drug Development
11%
Pharmaceutical Chemistry
11%
Wound
11%
Latent Tuberculosis
9%
Granuloma
9%
Dapsone
9%
Amoeba (Life Cycle Stage)
9%
Amoxicillin
9%
Tryptophan Synthase
9%
6 Diazo 5 Oxonorleucine
9%
Antibiotic-Resistant Bacteria
9%
Ruthenium Complex
9%
Avibactam
9%
Indole
9%
Dihydrofolate Reductase Inhibitor
9%
Chemogenomics
9%
Atypical Mycobacterium
9%
Nightmare
9%
Amikacin
9%
Fumarate Hydratase
9%
Polycyclic Aromatic Hydrocarbon
9%
Antimycobacterial
9%
Chalcone
9%
Diseases
9%
Microorganism
7%
Prevalence
7%
Drug Screening
6%
Fatty Acid Ester
6%
Penicillinase
6%
Combination Therapy
6%
Fatty Acid Synthase
6%
Ceftazidime
5%
Medicine and Dentistry
In Vitro
58%
Mycobacterium abscessus
54%
Infection
49%
Mycobacteria
28%
Antibiotic Resistance
23%
Antiinfective Agent
22%
Mycobacterium Tuberculosis
20%
Relebactam
18%
Cystic Fibrosis
18%
Imipenem
18%
Antibiotics
12%
Granuloma
12%
Amikacin
11%
Pathogen
11%
Azithromycin
9%
Latent Tuberculosis
9%
Antibiogram
9%
Sputum
9%
Amoxicillin
9%
Avibactam
9%
Dihydrofolate Reductase Inhibitor
9%
Chemogenomics
9%
Drug Sensitivity
9%
6 Diazo 5 Oxonorleucine
9%
Night Terror
9%
Atypical Mycobacterium
9%
Dapsone
9%
High Throughput Screening
7%
Soft Tissue Infection
6%
In Silico
6%
Immune System
6%
Bactericidal Activity
6%
Penicillinase
6%
Diseases
6%
Lung
5%
Ceftazidime
5%
Respiratory Tract Infection
5%
Lung Infection
5%
Hypoxia
5%